Sounds about right... the sales reps aren't calling on these PCP's yet as she obviously sends people to Colonoscopy. My PCP wanted to perform an iFOBT after he checked my prostate. Well we know an MDVIP doc would have obliged your request :)
Philadelphia, PA, October 23, 2014--In the past 10 years, the incidence of colorectal cancer (CRC) in patients younger than 50 years has risen alarmingly, according to research presented here at the annual scientific meeting and postgraduate course of the American College of Gastroenterology. Compared with older onset CRC, this young-onset CRC is more likely to be diagnosed in a minority population, and is pathologically much more aggressive.
Steph, this will be a great opportunity to educate your PCP. I spent some time with mine a while back and he ended up buying exas stock ;)
KC, under promises and over delivers consistently. If CG does nothing but replace 30% of the FIT market and 10% of the colonoscopy screening market, the opportunity is extraordinary. 502 puts us in a very profitable situation
A study published in The International Journal of Person Centered Medicine shows that patients in MDVIP practices comply with recommended preventive guidelines due to the fact that our doctors can spend more time with them and create a personalized wellness plan for each patient," says Dr. Klemes. "It is our hope that this new tool will lead to even greater numbers of our patients being screened for colorectal cancer."
I've noticed on the kaiser permanante website that under adult preventative care they list Fit, sigmoidoscopy or Colonscopy but not all 3 depending on the State. For instance, in California it's sig every 5 years or FIT annually. Is this within the affordable care act guidelines? or is this a means of cost containment? My question is why wouldn't all 3 be listed as options in all the states they do business? 20% of the screening pop. who are current in California use FIT/FOBT the highest of any state. I'm just thinking out loud here ;)
Under the ACA, CRC screening must be covered by private insurers with NO out of pocket costs. It will be early to mid 2015 when the USPSTF includes CG as either A or B rated thus enabling every American 50+ to use CG. According to USPSTF, the test and screening rates of those eligible are as follows.
“There are more than 20 million adults in this country who haven’t had any recommended screening for colorectal cancer and who may therefore get cancer and die from a preventable tragedy,” said CDC Director Tom Frieden, M.D., M.P.H. “Screening for colorectal cancer is effective and can save your life.”
EXAS swings at a high beta to the market.
the voice of truth.... i also believe in a counter intuitive way that this little biotech may become a safe haven for those who are seeking long term growth in an at present; very volatile market
Met, I read that the other day on on Medscape. I also read somewhere last week that the staging of the prep was important and then the process or how you went about it depending on when in the day you were having the colonoscopy. We know the challenge with the proximal colon coupled with the 25% chance of an inadequate prep both bode well for CG. I'm still buzzing over the reimbursement # :)
thanks .... yes i own lots of shares however i sold about 50k of them to purchase amrn about 2 years ago.... so that's the rest of the story. I'm still grateful to be a part of this story albeit in a small way.. these companies don't survive without the investors
So this was my first very naive post after i purchased in dec. of 2009 .... a poster on this board named chas123 was very helpful as was Mr. Luskin. I bought and held :) thanks to many others along the way who have been very informative and diligent in their research. God Bless this company in its mission to eradicate CRC and other GI cancers!!!!
yeah everyone needs to adjust their models ... yours truly had reimbursement pegged at 300 bucks and i was going to reload on the dip :) at 300 or 500 this was always going to go much higher
met, you've been around as long as i have if not longer :) you remember when this was in the 3's... the best is yet to come! tomorrow should be fun if 502 is the initial #
If that ends up being correct - it breaks down like this 81315= $282.83
82274= $ 21.70 or
you left out markers MRP8/14 and the words 'rapid results' so in adolescents we have less arthritis or cardiovascular related inflammation to confound results... the purpose is to rule out those at low risk for appendicitis avoiding a costly cat scan and unnecessary radiation exposure.